Press Releases

Date	Title	PDF Version
Apr 21, 2011	Alexion Reports First Quarter 2011 Results
Apr 08, 2011	Alexion Pharmaceuticals to Report First Quarter 2011 Results on Thursday, April 21, 2011
Apr 07, 2011	Alexion Submits Applications for Soliris® (Eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS) in the United States and European Union
Mar 30, 2011	Alexion Announces Two-For-One Stock Split
Mar 29, 2011	Alexion to Present at the 10th Annual Needham Healthcare Conference
Mar 01, 2011	Alexion to Present at the Cowen and Company 31st Annual Health Care Conference
Feb 28, 2011	Alexion Joins NORD, EURORDIS and Other Patient Advocacy Groups in Supporting the Goals of Rare Disease Day 2011
Feb 22, 2011	Alexion to Present at the Citi 2011 Global Health Care Conference
Feb 10, 2011	Alexion Reports Fourth Quarter and Full Year 2010 Results
Feb 10, 2011	Alexion Acquires Investigational Therapy for Infants Suffering From Catastrophic, Ultra-Rare Genetic Neurologic Disorder

Search